SpectraScience, Inc.

Equities

SCIE

US84760E3018

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 12:40:25 15/05/2024 am IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2021	SpectraScience : U.S. markets regulator suspends trading in defunct 'meme stock'	RE
2016	SpectraScience, Inc. Announces Presentation of WavSTAT4 Clinical Results for the Diagnosis of Small Colorectal Cancer Polyps	CI

Spectrascience Inc. announced that it expects to receive $40 million in funding.

October 06, 2014 at 09:30 am IST

Spectrascience Inc. (OTCPK:SCIE) announced a best effort private placement of equity financing for gross proceeds of $40 million on October 6, 2014. SenaHill Advisors, LLC acted as placement agent in the transaction.

Latest news about SpectraScience, Inc.

SpectraScience : U.S. markets regulator suspends trading in defunct 'meme stock'	11/21/11	RE
SpectraScience, Inc. Announces Presentation of WavSTAT4 Clinical Results for the Diagnosis of Small Colorectal Cancer Polyps	01/16/01	CI
SpectraScience Inc. Signs Distribution Agreement with Advanced Medical German Co	19/16/19	CI
SpectraScience Inc. Announces Licensing Agreement with Duke University	29/16/29	CI
SpectraScience and JagWorldwide Forge Distribution Agreement	03/15/03	CI
Spectrascience Inc. Announces Resignation of Chester E. Sievert as Director	06/15/06	CI
SpectraScience, Inc. Auditor Raises 'Going Concern' Doubt	20/15/20	CI
Spectrascience Inc. Appoints Rand Mulford to its Board	02/14/02	CI
Spectrascience Inc. announced that it expects to receive $40 million in funding.	06/14/06	CI
Spectrascience Mulls Acquisitions	06/14/06	CI
SpectraScience Announces SFDA Approval in Saudi Arabia for WavSTAT4	29/14/29	CI
Spectrascience Inc. announced that it has received $0.36 million in funding.	20/14/20	CI
Spectrascience Inc. announced that it expects to receive $0.36 million in funding.	11/14/11	CI
Spectrascience Inc. announced that it has received $0.26 million in funding.	20/13/20	CI
Spectrascience Inc. Appoints Lowell Giffhorn as Chief Financial Officer	04/13/04	CI
Spectrascience Inc. announced that it expects to receive $0.95 million in funding.	03/13/03	CI
Spectrascience Inc. Announces Executive Changes	06/13/06	CI
Spectrascience Inc. Provides Revenue Guidance for the Second Quarter Ending June 30, 2013	27/13/27	CI
Spectrascience Inc. announced that it has received $0.91 million in funding.	14/13/14	CI
SpectraScience, Inc. Announces Positive Results From Study by Dr. Helmut Neumann	11/13/11	CI
SpectraScience, Inc. Auditor Raises 'Going Concern' Doubt	18/13/18	CI
SpectraScience, Inc. and PENTAX Europe GmbH Announce Expanded Distribution of WavSTAT4 Optical Biopsy System in Europe	10/13/10	CI
Spectrascience Inc. Demonstrates WavSTAT4 Optical Biopsy System at Arab Health 2013	30/13/30	CI
Spectrascience Inc. announced that it expects to receive $1 million in funding.	30/13/30	CI
Spectrascience Inc. announced that it has received $0.11 million in funding.	31/12/31	CI

Chart SpectraScience, Inc.

Duration

Period

More charts

Company Profile

SpectraScience, Inc. is focused on developing its WavSTAT Optical Biopsy System (WavSTAT). The WavSTAT employs a risk technology that optically illuminates tissue in real-time to distinguish between normal and pre-cancerous or cancerous tissue. The Company has developed a technology platform to determine if tissue is normal, pre-cancerous or cancerous, without the need for a physical biopsy. The WavSTAT4 Optical Biopsy System operates by using cool, safe ultraviolet (UV) laser light to optically illuminate and analyze tissue, enabling the physician to make a diagnosis during endoscopy when screening for cancer and, if warranted, to begin immediate treatment during the same procedure. The WavSTAT4 uses laser-induced auto-fluorescence to obtain spectral information from tissue at the suspected site. The system is classified as a non-significant risk device, which transmits low-level UV laser light energy through an optical fiber to the tissue through the working channel of an endoscope.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
SPECTRASCIENCE, INC.	0.00%	4.97K
THERMO FISHER SCIENTIFIC	+12.85%	229B
DANAHER CORPORATION	+13.88%	195B
INTUITIVE SURGICAL, INC.	+18.39%	142B
BOSTON SCIENTIFIC CORPORATION	+28.78%	109B
SIEMENS HEALTHINEERS AG	+1.71%	64.85B
EDWARDS LIFESCIENCES CORPORATION	+18.24%	54.33B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+7.04%	52.09B
AGILENT TECHNOLOGIES, INC.	+10.83%	45.15B
GE HEALTHCARE TECHNOLOGIES INC.	+5.94%	37.39B

Other Advanced Medical Equipment & Technology